MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Affective theory of mind in Parkinson’s disease

    A.M. Hammad, S. Ghozy, S.I. El-Jaafary (Cairo, Egypt)

    Objective: The aim of this study is to assess the hypothesis that patients with PD may show difficulties in tasks related to affective theory of…
  • 2016 International Congress

    Correlation between self-perceived balance confidence, postural control, gait and quality of life of individuals with Parkinson’s disease

    J.E. Pompeu, K.G. Silva, T.B. Freitas, F. Doná, C. Torriani-Pasin, R.A. Nuvolini (São Paulo, Brazil)

    Objective: To examine the association of self-perceived balance confidence level with postural control, gait and the quality of life in Parkinson's disease (PD) people on…
  • 2016 International Congress

    Validation of the Hebrew version of the International Parkinson and Movement Disorder Society—unified Parkinson’s disease rating scale (MDS-UPDRS)

    J. Zitser, A. Bar David, H. Shabtai, A. Ezra, M. Brozgol, C. Peretz, A. Rozenberg, T. Herman, G.T. Setbbins, C.G. Goetz, B.C. Tilley, S.T. Luo, L. Wang, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To assess the clinimetric properties of the Hebrew version of the MDS-UPDRS. Background: The Unified Parkinson's disease Rating Scale (UPDRS) is a rating scale…
  • 2016 International Congress

    Assessment of oral hygiene status before and after the use of powered tooth brush in patients with Parkinson’s diseases

    F. Pullishery, F.M. Kuyyadi (Malappuram, India)

    Objective: The objective of this study was to assess the oral hygiene status, gingival status and also the Oral health related quality of life (OHRQoL)…
  • 2016 International Congress

    Participant feedback in the PREDICT-PD study

    C.W. Osborne, J. Bestwick, G. Giovannoni, A.J. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To explore the underlying motivation behind participation in PREDICT-PD and whether this had an influence on later drop out from the study. Background: The…
  • 2016 International Congress

    Tear fluid as potential biomarker for the diagnosis of Parkinson’s disease

    M. Börger, S. Funke, F. Maaß, A. Fischbach, M. Bähr, F. Grus, P. Lingor (Göttingen, Germany)

    Objective: This study compares tear fluid proteome in patients with idiopathic Parkinson´s disease (PD) and age-matched healthy controls (HC) to characterize disease-related proteomic changes and…
  • 2016 International Congress

    Effects of exercise intervention on balance and gait performance, and balance confidence in people with Parkinson’s disease – A meta-analysis

    M.K. Mak, I.S. Wong-Yu (Hong Kong, People's Republic of China)

    Objective: To examine the short- and long-term effects of exercise intervention on enhancing balance, and gait performance, and balance confidence in Parkinson's disease (PD) population,…
  • 2016 International Congress

    Nilotinib improves motor skills, cognition and autonomic function in open-label phase I clinical trial in Parkinson’s disease with dementia and Lewy body dementia

    F. Pagan, E. Valadez, Y. Torres-Yaghi, A. Keys, R. Falconer, S. Rogers, B. Wilmarth, M. Hebron, C. Moussa (Washington, DC, USA)

    Objective: Nilotinib, a tyrosine kinase inhibitor (TKI) was examined with the aim of showing its effect on safety comparing a lower dose of 150mg (N=6)…
  • 2016 International Congress

    The NIC-PD-study –Baseline data of a randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson’s disease in Germany and the USA

    W.H. Oertel, C. Brittinger, C. Kamp, K. Balthasar, K. Articus, M. Brinkman, C. Venuto, H. Mueller, M.M. Unger, K.M. Eggert, D. Vadasz, K. Kieburtz, J. Boyd (Marburg, Germany)

    Objective: The primary endpoint of clinical progression is measured by change in the total UPDRS score between baseline and 1) after 52 weeks of study…
  • 2016 International Congress

    The application of mobile health technology to increase physical activity in persons with Parkinson’s disease

    T.D. Ellis, T.R. DeAngelis, K. Hendron, J.T. Cavanaugh, N. Sullivan, L. Goehring, C.A. Thomas, M. Saint-Hilaire, N.K. Latham (Boston, MA, USA)

    Objective: To investigate the safety, acceptability and preliminary evidence of efficacy of a mobile health (mhealth) mediated home-based exercise program to increase physical activity in…
  • « Previous Page
  • 1
  • …
  • 358
  • 359
  • 360
  • 361
  • 362
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley